Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-028858

Chief Commercial Officer gave up 1,153 shares (to pay taxes)

  • Chief Commercial Officer acquired 4,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Fair Brett Chief Commercial Officer 2018-05-07 Option exercise +4,050 7,191 D: show line 1 in the form
Fair Brett Chief Commercial Officer 2018-05-07 Shares withheld for taxes −1,153 $18.10 $20,869 6,038 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Fair Brett Chief Commercial Officer 2018-05-07 Option exercise · Restricted Stock Units −4,050 3,038 D: show line 3 in the form
Loading xslF345X03/doc4.xml…